Hasil Pencarian - Burcu Yigit

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models

    205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models oleh Burcu Yigit, Xavier Michelet, Darrian Moskowitz, Marc Van Dijk, Antoine Tanne

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    164 AgenT-797, a novel allogenic and ‘off-the shelf’ iNKT cell therapy promotes effective tumor killing

    164 AgenT-797, a novel allogenic and ‘off-the shelf’ iNKT cell therapy promotes effective tumor killing oleh Burcu Yigit, Xavier Michelet, Shalu Kharkwal, Eleni Chantzoura, Jan Bergmann, Alvaro Sebastian Yague, Simon Yue, Darrian Moskowitz, Benjamin Wolf, Mark Exley

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The Checkpoint Regulator SLAMF3 Preferentially Prevents Expansion of Auto-Reactive B Cells Generated by Graft-vs.-Host Disease

    The Checkpoint Regulator SLAMF3 Preferentially Prevents Expansion of Auto-Reactive B Cells Generated by Graft-vs.-Host Disease oleh Ninghai Wang, Burcu Yigit, Cees E. van der Poel, Marta Cuenca, Michael C. Carroll, Roland W. Herzog, Pablo Engel, Cox Terhorst

    Diterbitkan 2019-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Migration of myeloid cells during inflammation is differentially regulated by the cell surface receptors Slamf1 and Slamf8.

    Migration of myeloid cells during inflammation is differentially regulated by the cell surface receptors Slamf1 and Slamf8. oleh Guoxing Wang, Boaz J van Driel, Gongxian Liao, Michael S O'Keeffe, Peter J Halibozek, Jacky Flipse, Burcu Yigit, Veronica Azcutia, Francis W Luscinskas, Ninghai Wang, Cox Terhorst

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome

    A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome oleh Terese C. Hammond, Marco A. Purbhoo, Sapana Kadel, Jerome Ritz, Sarah Nikiforow, Heather Daley, Kit Shaw, Koen van Besien, Alexandra Gomez-Arteaga, Don Stevens, Waldo Ortuzar, Xavier Michelet, Rachel Smith, Darrian Moskowitz, Reed Masakayan, Burcu Yigit, Shannon Boi, Kah Teong Soh, John Chamberland, Xin Song, Yu Qin, Ilya Mishchenko, Maurice Kirby, Valeriia Nasonenko, Alexa Buffa, Jennifer S. Buell, Dhan Chand, Marc van Dijk, Justin Stebbing, Mark A. Exley

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: